A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE by Lavinia Tan, Chris Brown, Antony Mersiades, Chee Khoon Lee, Thomas John, Steven Kao, Genni Newnham, Kenneth O’Byrne, Sagun Parakh, Victoria Bray, Kevin Jasas, Sonia Yip, Stephen Q. Wong, Sarah Ftouni, Jerick Guinto, Sushma Chandrashekar, Stephen Clarke, Nick Pavlakis, Martin R. Stockler, Sarah-Jane Dawson, Benjamin J. Solomon

Get full text

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study by Lauren Julia Brown, Lauren Julia Brown, Lauren Julia Brown, Lauren Julia Brown, Victor Khou, Victor Khou, Victor Khou, Chris Brown, Marliese Alexander, Marliese Alexander, Dasantha Jayamanne, Dasantha Jayamanne, Dasantha Jayamanne, Joe Wei, Lauren Gray, Wei Yen Chan, Wei Yen Chan, Samuel Smith, Susan Harden, Susan Harden, Antony Mersiades, Antony Mersiades, Lydia Warburton, Lydia Warburton, Malinda Itchins, Malinda Itchins, Malinda Itchins, Jenny H. Lee, Jenny H. Lee, Nick Pavlakis, Nick Pavlakis, Nick Pavlakis, Stephen J. Clarke, Stephen J. Clarke, Stephen J. Clarke, Michael Boyer, Michael Boyer, Adnan Nagrial, Adnan Nagrial, Adnan Nagrial, Eric Hau, Eric Hau, Eric Hau, Eric Hau, Ines Pires da Silva, Ines Pires da Silva, Ines Pires da Silva, Steven Kao, Steven Kao, Benjamin Y. Kong, Benjamin Y. Kong, Benjamin Y. Kong, Benjamin Y. Kong

Get full text